CLAIRIGENE
Startup
CLAIRIGENE
Description
CLAIRIgene develops targeted epigenome therapy designed for unmet medical needs in CNS disorders such as Alzheimer's and other neurodegenerative diseases.
CLAIRIGENE
Address
Poland
Contact
Description
CLAIRIgene develops targeted epigenome therapy designed for unmet medical needs in CNS disorders such as Alzheimer's and other neurodegenerative diseases.
Matchmaking
Connect with CLAIRIGENE
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways